Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FQW0V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $50,429
Award facts
- Contract value 100% obligated
- $50,428.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $50,428.56 delivery order to AmerisourceBergen Drug Corp for the supply of 200-unit vials of Xeomin on February 4, 2026, with an ultimate completion date of February 26, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.999 billion through December 31, 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in federal medical procurement, particularly for the Department of Defense and military healthcare systems. The company's role as a prime vendor under the DLA Troop Support Medical IDC enables it to deliver a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. This specific delivery order for Xeomin, a botulinum toxin product used in medical applications, exemplifies the company's capability to fulfill targeted pharmaceutical requirements within the broader global pharmaceutical support framework.
Quick answers
Who was awarded contract SPE2DR26FQW0V?
SPE2DR26FQW0V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FQW0V worth?
The government has obligated $50,429 on SPE2DR26FQW0V.
Is contract SPE2DR26FQW0V an order under another contract?
Yes. SPE2DR26FQW0V is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQW0V competed?
The extent of competition for SPE2DR26FQW0V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award